Description

Treatment for wet age-related macular degeneration has advanced significantly with anti-VEGF therapies, but the need for frequent injections remains a challenge. A new, longer-lasting treatment now in development aims to reduce treatment burden while helping preserve vision.

This podcast was produced for Ocular Therapeutix by Scientific American Custom Media, a division separate from the magazine’s board of editors.

Learn more
about your ad choices. Visit megaphone.fm/adchoices

 











Learn more about your ad choices. Visit megaphone.fm/adchoices